Industry: 'Learn From COVID And Cut EU Drug Review Times'

Change Could Help In Reimbursement And Access Decisions

 
• By Ian Schofield
  
New oncology drugs could benefit from faster EU decision-making • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography